目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 33)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 38)
2.1 RESEARCH APPROACH
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: CLINICAL TRIAL SUPPLIES MARKET
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
FIGURE 3 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 MARKET SIZE ESTIMATION APPROACH: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
FIGURE 5 MARKET SIZE ESTIMATION APPROACH: PARENT MARKET (TOP-DOWN APPROACH)
FIGURE 6 CLINICAL TRIAL SUPPLIES MARKET: FINAL MARKET SIZE (USD BILLION)
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 7 GROWTH RATE ASSUMPTION BASED ON MARKET DYNAMICS
FIGURE 8 FINAL CAGR PROJECTIONS (2021−2026)
2.4 INSIGHTS FROM PRIMARIES
FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 46)
FIGURE 10 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY TYPE, 2020 VS. 2026
FIGURE 11 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY SERVICE, 2020
FIGURE 12 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2021 VS. 2026
FIGURE 13 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY THERAPEUTIC AREA, 2020
FIGURE 14 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY END USER, 2020
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL TRIAL SUPPLIES MARKET

4 PREMIUM INSIGHTS (Page No. - 50)
4.1 CLINICAL TRIAL SUPPLIES MARKET OVERVIEW
FIGURE 16 INCREASING R&D INVESTMENTS TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SHARE, BY TYPE & COUNTRY (2020)
FIGURE 17 SMALL-MOLECULE DRUGS ACCOUNTED FOR THE LARGEST SHARE OF THE CLINICAL TRIAL SUPPLIES MARKET IN NORTH AMERICA
4.3 CLINICAL TRIAL SUPPLIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE CLINICAL TRIAL SUPPLIES MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 CLINICAL TRIAL SUPPLIES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.3 IMPACT ANALYSIS
5.3.1 DRIVERS
5.3.1.1 Increasing R&D expenditure of pharmaceutical and biopharmaceutical companies
TABLE 2 R&D EXPENDITURE OF LEADING PHARMACEUTICAL COMPANIES IN 2019
FIGURE 20 NUMBER OF PHARMA COMPANIES WITH ACTIVE DRUG PIPELINE PROJECTS (2010-2020)
FIGURE 21 GLOBAL R&D SPENDING (2016-2020)
5.3.1.2 Increasing number of registered clinical trials
FIGURE 22 NUMBER OF CLINICAL TRIALS IN THE LAST 10 YEARS
5.3.1.3 Increasing decentralization of clinical trials
5.3.2 RESTRAINTS
5.3.2.1 High cost of drug development
5.3.3 OPPORTUNITIES
5.3.3.1 Emerging markets
5.4 RANGES/SCENARIOS
FIGURE 23 DEPENDING ON HOW UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE CLINICAL TRIAL SUPPLIES MARKET
5.5 COVID-19 IMPACT ANALYSIS
FIGURE 24 NUMBER OF CLINICAL TRIALS, BY PHASE (2020-2021)
FIGURE 25 NUMBER OF CLINICAL TRIALS, BY COUNTRY
5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 26 PRE-COVID-19 VS. POST-COVID-19 SCENARIO
5.7 VALUE CHAIN ANALYSIS
FIGURE 27 VALUE CHAIN ANALYSIS OF THE CLINICAL TRIAL SUPPLIES MARKET
5.8 ECOSYSTEM/MARKET MAP
5.9 SUPPLY CHAIN
5.10 PORTER’S FIVE FORCES ANALYSIS
5.10.1 PORTER’S 5 FORCES IMPACT ON THE CLINICAL TRIAL SUPPLIES MARKET
5.10.1.1 Threat from new entrants
5.10.1.2 Threat from substitutes
5.10.1.3 Bargaining power of suppliers
5.10.1.4 Bargaining power of buyers
5.10.1.5 Degree of competition
5.11 REGULATORY LANDSCAPE
5.11.1 INTRODUCTION

6 CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE (Page No. - 68)
6.1 INTRODUCTION
TABLE 3 CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
6.2 LOGISTICS & DISTRIBUTION
6.2.1 INCREASING COMPLEXITY, EVOLVING TREATMENT PROTOCOLS, TECHNOLOGICAL ADVANCEMENTS, AND DATA SECURITY CHALLENGES TO DRIVE THE DEMAND FOR LOGISTICS & DISTRIBUTION SERVICES
TABLE 4 CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY REGION, 2019-2026 (USD MILLION)
TABLE 5 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 6 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 7 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
6.3 STORAGE & RETENTION
6.3.1 GROWING DEMAND FOR DIRECT-TO-PATIENT AND DIRECT-TO-SITE SERVICES TO DRIVE GROWTH IN THE STORAGE & RETENTION SERVICES MARKET SEGMENT
TABLE 8 CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY REGION, 2019-2026 (USD MILLION)
TABLE 9 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 10 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 11 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
6.4 PACKAGING, LABELING, AND BLINDING
6.4.1 RISING DEMAND FOR ADVANCED PACKAGING TO DRIVE THIS MARKET SEGMENT.
TABLE 12 CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY REGION, 2019-2026 (USD MILLION)
TABLE 13 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 14 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 15 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
6.5 MANUFACTURING
6.5.1 GROWING FOCUS OF COMPANIES ON INCREASING THEIR MANUFACTURING CAPACITIES TO DRIVE MARKET GROWTH
TABLE 16 CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY REGION, 2019-2026 (USD MILLION)
TABLE 17 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 18 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 19 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
6.6 COMPARATOR SOURCING
6.6.1 INTENSE MARKET COMPETITION, REGULATORY PRESSURE, INCREASING NUMBER OF CO-THERAPIES, AND THE RISING NUMBER OF CLINICAL TRIALS IN EMERGING COUNTRIES TO DRIVE GROWTH IN THIS SEGMENT
TABLE 20 CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY REGION, 2019-2026 (USD MILLION)
TABLE 21 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 22 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 23 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
6.7 OTHER SERVICES
TABLE 24 CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY REGION, 2019-2026 (USD MILLION)
TABLE 25 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 26 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 27 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY COUNTRY, 2019-2026 (USD MILLION)

7 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE (Page No. - 82)
7.1 INTRODUCTION
TABLE 28 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
7.2 PHASE III
7.2.1 SINCE PHASE III TRIALS INVOLVE A LARGE PATIENT POPULATION, THE DEMAND FOR OUTSOURCING OF CLINICAL TRIAL SUPPLIES IS HIGH IN THIS PHASE
TABLE 29 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III CLINICAL TRIALS, BY REGION, 2019-2026 (USD MILLION)
TABLE 30 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 31 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 32 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
7.3 PHASE II
7.3.1 PHASE II CLINICAL TRIALS HELP IN UNDERSTANDING THE EFFECTIVENESS OF THE DRUG AND FURTHER EVALUATING ITS SAFETY—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 33 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II CLINICAL TRIALS, BY REGION, 2019-2026 (USD MILLION)
TABLE 34 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 35 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 36 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
7.4 PHASE I
7.4.1 QUALITY OF CLINICAL TRIAL SUPPLIES AND LOGISTICS PLAY A VITAL ROLE IN PHASE I CLINICAL TRIALS
TABLE 37 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I CLINICAL TRIALS, BY REGION, 2019-2026 (USD MILLION)
TABLE 38 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 39 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 40 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
7.5 PHASE IV
7.5.1 THESE STUDIES PRIMARILY ALLOW RESEARCHERS TO FIND AND OBSERVE THE LONG-TERM EFFECTS OF A PARTICULAR DRUG IN A CONSIDERABLY LARGER POOL OF PATIENTS—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 41 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV CLINICAL TRIALS, BY REGION, 2019-2026 (USD MILLION)
TABLE 42 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 43 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 44 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2019-2026 (USD MILLION)
7.6 BA/BE STUDIES
7.6.1 INCREASING PATENT EXPIRATION TO INCREASE THE DEMAND FOR BA/BE STUDIES
TABLE 45 CLINICAL TRIAL SUPPLIES MARKET FOR BA/BE STUDIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 46 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BA/BE STUDIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 47 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR BA/BE STUDIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 48 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR BA/BE STUDIES, BY COUNTRY, 2019-2026 (USD MILLION)

8 CLINICAL TRIAL SUPPLIES MARKET, BY TYPE (Page No. - 93)
8.1 INTRODUCTION
TABLE 49 CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
8.2 SMALL-MOLECULE DRUGS
8.2.1 LOW COST OF DEVELOPING SMALL-MOLECULE DRUGS TO DRIVE MARKET GROWTH
TABLE 50 CLINICAL TRIAL SUPPLIES MARKET FOR SMALL-MOLECULE DRUGS, BY REGION, 2019-2026 (USD MILLION)
TABLE 51 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL-MOLECULE DRUGS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 52 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL-MOLECULE DRUGS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 53 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL-MOLECULE DRUGS, BY COUNTRY, 2019-2026 (USD MILLION)
8.3 BIOLOGIC DRUGS
8.3.1 BIOLOGIC DRUGS HAVE A RELATIVELY LOW RATE OF ATTRITION COMPARED TO SMALL-MOLECULE DRUGS—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 54 CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGIC DRUGS, BY REGION, 2019-2026 (USD MILLION)
TABLE 55 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGIC DRUGS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 56 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGIC DRUGS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 57 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGIC DRUGS, BY COUNTRY, 2019-2026 (USD MILLION)
8.4 MEDICAL DEVICES
8.4.1 INCREASING NUMBER OF TRIALS FOR MEDICAL DEVICES TO DRIVE MARKET GROWTH
TABLE 58 CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES, BY REGION, 2019-2026 (USD MILLION)
TABLE 59 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 60 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 61 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2019-2026 (USD MILLION)

9 CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA (Page No. - 100)
9.1 INTRODUCTION
TABLE 62 CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
9.2 ONCOLOGY
9.2.1 GROWING STUDIES ON CANCER THERAPEUTICS TO DRIVE MARKET GROWTH
TABLE 63 CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY REGION, 2019-2026 (USD MILLION)
TABLE 64 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 65 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 66 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
9.3 CNS & MENTAL DISORDERS
9.3.1 INCREASING CASES OF MENTAL DISORDERS TO DRIVE MARKET GROWTH
TABLE 67 CLINICAL TRIAL SUPPLIES MARKET FOR CNS & MENTAL DISORDERS, BY REGION, 2019-2026 (USD MILLION)
TABLE 68 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR CNS & MENTAL DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 69 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR CNS & MENTAL DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 70 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR CNS & MENTAL DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
9.4 CARDIOVASCULAR DISEASES
9.4.1 GROWING INVESTMENTS BY PHARMACEUTICAL COMPANIES FOR CVD RESEARCH TO DRIVE GROWTH IN THIS MARKET SEGMENT
TABLE 71 CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2019-2026 (USD MILLION)
TABLE 72 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 73 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 74 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
9.5 DIGESTIVE DISORDERS
9.5.1 INCREASING R&D FOR THE DEVELOPMENT OF EFFECTIVE DRUGS TO DRIVE THE DEMAND FOR CLINICAL TRIAL SUPPLIES FOR THIS THERAPEUTIC AREA
TABLE 75 CLINICAL TRIAL SUPPLIES MARKET FOR DIGESTIVE DISORDERS, BY REGION, 2019-2026 (USD MILLION)
TABLE 76 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR DIGESTIVE DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 77 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR DIGESTIVE DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 78 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR DIGESTIVE DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
9.6 INFECTIOUS DISEASES
9.6.1 EMERGENCE OF NEW INFECTIONS SUCH AS EBOLA, ZIKA, AND COVID-19 HAS ACCELERATED THE EFFORTS TO DEVELOP NEW DRUGS—THIS WILL DRIVE THE DEMAND FOR CLINICAL TRIAL SUPPLIES
TABLE 79 CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019-2026 (USD MILLION)
TABLE 80 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 81 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 82 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
9.7 METABOLIC DISORDERS
9.7.1 INCREASING PREVALENCE OF DIABETES AND OTHER METABOLIC DISORDERS TO DRIVE MARKET GROWTH IN THE COMING YEARS
FIGURE 28 ESTIMATED NUMBER OF INDIVIDUALS WITH DIABETES FROM 2000 TO 2045 (IN MILLIONS)
TABLE 83 CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS, BY REGION, 2019-2026 (USD MILLION)
TABLE 84 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 85 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 86 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
9.8 BLOOD DISORDERS
9.8.1 GROWTH IN THE NUMBER OF HEMOPHILIA PATIENTS TO BOOST THE PRODUCTION OF MACROMOLECULES AND RECOMBINANT FACTORS
TABLE 87 CLINICAL TRIAL SUPPLIES MARKET FOR BLOOD DISORDERS, BY REGION, 2019-2026 (USD MILLION)
TABLE 88 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BLOOD DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 89 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR BLOOD DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 90 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR BLOOD DISORDERS, BY COUNTRY, 2019-2026 (USD MILLION)
9.9 IMMUNOLOGY
9.9.1 CONTINUOUS GROWTH IN CLINICAL STUDIES FOR IMMUNE SYSTEM DISEASES TO FUEL THE NEED FOR PROCURING CLINICAL TRIAL SUPPLIES
TABLE 91 CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGY, BY REGION, 2019-2026 (USD MILLION)
TABLE 92 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 93 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 94 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
9.10 OTHER THERAPEUTIC AREAS
TABLE 95 CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2019-2026 (USD MILLION)
TABLE 96 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 97 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 98 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2019-2026 (USD MILLION)

10 CLINICAL TRIAL SUPPLIES MARKET, BY END USER (Page No. - 120)
10.1 INTRODUCTION
TABLE 99 CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.2.1 INCREASING R&D INVESTMENTS TO BOOST THE OUTSOURCING OF CLINICAL TRIAL SUPPLIES BY PHARMACEUTICAL AND BIOTECH COMPANIES
TABLE 100 CLINICAL TRIAL SUPPLIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 101 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 102 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 103 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
10.3 CONTRACT RESEARCH ORGANIZATIONS
10.3.1 INCREASING OUTSOURCING OF CLINICAL TRIALS TO DRIVE THE ADOPTION OF CLINICAL TRIAL SUPPLIES AMONG CROS
TABLE 104 CLINICAL TRIAL SUPPLIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2026 (USD MILLION)
TABLE 105 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 106 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 107 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
10.4 MEDICAL DEVICE COMPANIES
10.4.1 INCREASING NUMBER OF TRIALS OF MEDICAL DEVICES TO DRIVE MARKET GROWTH
TABLE 108 CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 109 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 110 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 111 APAC: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)

11 CLINICAL TRIAL SUPPLIES MARKET, BY REGION (Page No. - 127)
11.1 INTRODUCTION
FIGURE 29 CLINICAL TRIAL SUPPLIES MARKET: GEOGRAPHICAL SNAPSHOT
TABLE 112 CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2019-2026 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SNAPSHOT
TABLE 113 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 114 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 115 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 116 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 117 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 118 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.2.1 US
11.2.1.1 Increasing R&D investments to drive market growth in the US
TABLE 119 US: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 120 US: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 121 US: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 122 US: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 123 US: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Growing preference of pharmaceutical companies to conduct trials in Canada to favor market growth
TABLE 124 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 125 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 126 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 127 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 128 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3 EUROPE
TABLE 129 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 130 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 131 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 132 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 133 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 134 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Growing number of sponsored trials to boost the demand for clinical trial supplies in Germany
TABLE 135 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 136 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 137 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 138 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 139 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.2 UK
11.3.2.1 Government policies leading to costlier R&D and supply chain restrictions post Brexit to limit market growth to a certain extent
TABLE 140 UK: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 141 UK: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 142 UK: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 143 UK: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 144 UK: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Presence of leading pharmaceutical companies to support market growth in France
TABLE 145 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 146 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 147 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 148 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 149 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Increasing number of drug approvals to drive the market for clinical trial supplies in Italy
TABLE 150 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 151 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 152 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 153 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 154 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Increasing biologics production to support market growth in Spain
TABLE 155 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 156 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 157 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 158 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 159 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.6 SWITZERLAND
11.3.6.1 Growing R&D efforts to provide growth opportunities for the clinical trial supplies market in Switzerland
TABLE 160 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 161 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 162 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 163 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 164 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 165 ROE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 166 ROE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 167 ROE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 168 ROE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 169 ROE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SNAPSHOT
TABLE 170 APAC: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 171 APAC: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 172 APAC: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 173 APAC: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 174 APAC: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 175 APAC: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.1 CHINA
11.4.1.1 Favorable government regulations are boosting the market growth in China
TABLE 176 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 177 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 178 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 179 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 180 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Government initiatives for drug innovation to support market growth in Japan
TABLE 181 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 182 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 183 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 184 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 185 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Low manufacturing costs and a skilled workforce are factors attracting outsourcing and investment to India
TABLE 186 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 187 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 188 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 189 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 190 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 Australia has many research institutes conducting clinical trials—this is a key factor boosting the growth of the market
TABLE 191 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 192 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 193 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 194 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 195 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.5 SOUTH KOREA
11.4.5.1 Government investments are a key contributor to market growth in South Korea
TABLE 196 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 197 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 198 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 199 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 200 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.6 SINGAPORE
11.4.6.1 Presence of world-class infrastructure to drive market growth in Singapore
TABLE 201 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 202 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 203 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 204 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 205 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 206 ROAPAC: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 207 ROAPAC: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 208 ROAPAC: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 209 ROAPAC: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 210 ROAPAC: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.5 ROW
TABLE 211 ROW: CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2019-2026 (USD MILLION)
11.5.1 LATIN AMERICA
11.5.1.1 Growing R&D expenditure in the pharmaceutical and biopharmaceutical sector to drive market growth in Latin America
TABLE 212 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 213 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 214 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 215 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 216 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)
11.5.2 MIDDLE EAST & AFRICA
11.5.2.1 Growing presence of pharmaceutical companies to drive market growth in the Middle East & Africa
TABLE 217 MIDDLE EAST & AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2019-2026 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2019-2026 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2019-2026 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2019-2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 181)
12.1 INTRODUCTION
12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 32 CLINICAL TRIAL SUPPLIES MARKET: STRATEGIES ADOPTED
12.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 33 KEY PLAYERS IN THE CLINICAL TRIAL SUPPLIES MARKET
12.4 MARKET SHARE ANALYSIS
FIGURE 34 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2020
12.5 COMPANY EVALUATION QUADRANT
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 35 CLINICAL TRIAL SUPPLIES MARKET: COMPANY EVALUATION QUADRANT, 2020
12.6 CLINICAL TRIAL SUPPLIES MARKET: SME EVALUATION
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
FIGURE 36 CLINICAL TRIAL SUPPLIES MARKET: COMPANY EVALUATION QUADRANT FOR SMES, 2020
12.7 COMPETITIVE BENCHMARKING
12.7.1 COMPANY SERVICE FOOTPRINT (25 COMPANIES)
FIGURE 37 COMPANY PORTFOLIO FOOTPRINT: CLINICAL TRIAL SUPPLIES MARKET
TABLE 222 COMPANY REGION FOOTPRINT (25 COMPANIES)
TABLE 223 COMPANY SERVICE OFFERING FOOTPRINT (25 COMPANIES)
12.8 GROWTH STRATEGIES ADOPTED BY MAJOR AND EMERGING PLAYERS
12.8.1 CLINICAL TRIAL SUPPLIES MARKET: SERVICE LAUNCHES (JANUARY 2018 TO JUNE 2021)

13 COMPANY PROFILES (Page No. - 194)
13.1 MAJOR PLAYERS
(Business Overview, Services Offered, Recent Developments, and Right to Win)*
13.1.1 CATALENT, INC.
TABLE 224 CATALENT, INC.: BUSINESS OVERVIEW
FIGURE 38 CATALENT, INC.: COMPANY SNAPSHOT (2020)
13.1.2 PAREXEL
TABLE 225 PAREXEL: BUSINESS OVERVIEW
13.1.3 BIOCAIR
TABLE 226 BIOCAIR: BUSINESS OVERVIEW
13.1.4 ALMAC GROUP
TABLE 227 ALMAC GROUP: BUSINESS OVERVIEW
13.1.5 THERMO FISHER SCIENTIFIC
TABLE 228 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 39 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
13.1.6 PIRAMAL PHARMA SOLUTIONS
TABLE 229 PIRAMAL PHARMA SOLUTIONS: BUSINESS OVERVIEW
FIGURE 40 PIRAMAL PHARMA SOLUTIONS: COMPANY SNAPSHOT (2020)
13.1.7 UDG HEALTHCARE
TABLE 230 UDG HEALTHCARE: BUSINESS OVERVIEW
FIGURE 41 UDG HEALTHCARE: COMPANY SNAPSHOT (2020)
13.1.8 EUROFINS
TABLE 231 EUROFINS: BUSINESS OVERVIEW
FIGURE 42 EUROFINS: COMPANY SNAPSHOT (2020)
13.1.9 MARKEN (A SUBSIDIARY OF UPS)
TABLE 232 UPS: BUSINESS OVERVIEW
FIGURE 43 UPS: COMPANY SNAPSHOT (2020)
13.1.10 INFOSYS
TABLE 233 INFOSYS: BUSINESS OVERVIEW
FIGURE 44 INFOSYS: COMPANY SNAPSHOT (2020)
13.1.11 PCI PHARMA SERVICES
TABLE 234 PCI PHARMA SERVICES: BUSINESS OVERVIEW
13.1.12 PRA HEALTH SCIENCES
TABLE 235 PRA HEALTH SCIENCES: BUSINESS OVERVIEW
FIGURE 45 PRA HEALTH SCIENCES: COMPANY SNAPSHOT (2019)
13.1.13 LIVEO RESEARCH (FORMERLY BILCARE RESEARCH)
TABLE 236 BILCARE RESEARCH: BUSINESS OVERVIEW
FIGURE 46 BILCARE RESEARCH: COMPANY SNAPSHOT (2020)
13.1.14 CAPSUGEL (ACQUIRED BY LONZA GROUP)
TABLE 237 LONZA GROUP: BUSINESS OVERVIEW
FIGURE 47 LONZA GROUP: COMPANY SNAPSHOT (2020)
* Business Overview, Services Offered, Recent Developments, and Right to Win might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS
13.2.1 SIRO CLINPHARM
13.2.2 KLIFO
13.2.3 CLINIGEN
13.2.4 ANCILLARE
13.2.5 N-SIDE
13.2.6 ADALLEN PHARMA
13.2.7 RUBICON RESEARCH
13.2.8 DURBIN
13.2.9 RECIPHARM
13.2.10 SEVEILLAR CLINICAL SUPPLIES SERVICES
13.2.11 MYONEX (FORMERLY MYODERM)

14 APPENDIX (Page No. - 235)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS